Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

About Browse conditions ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

Secondary Prevention of Clostridioides Difficile Using Vancomycin — Stella

Home/Clostridioides Difficile Infection/Secondary Prevention of Clostridioides Difficile Using Vancomycin

View on ClinicalTrials.gov

Recruiting

Back to Clostridioides Difficile Infection trials

Secondary Prevention of Clostridioides Difficile Using Vancomycin

Phase 2 — Testing in a larger group (up to a few hundred people) to further evaluate safety and begin to assess effectiveness.

Trial locations(1 site)

Canada

McGill University Health Centre, Montreal, Quebec

Key details

Phase

Safety & dosing / Large-scale testing

Sponsor

McGill University Health Centre/Research Institute of the McGill University Health Centre

Enrollment target

~300 participants

Started

October 2025

Primary completion

October 2028

Age range

18 Years and older

Last updated September 2025

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Stella acts as an intermediary. Researcher contact info is never exposed.

Follow this trial

Get notified in plain English when this trial's status changes. No account required.